S-892216 Long-acting Injectable
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S-892216 Long-acting Injectable, covering 2025-08-27 to 2025-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants [Phase 1]